RIL
TVTX icon

Rothschild Investment LLC’s Travere Therapeutics TVTX Stock Holding History

Rothschild Investment LLC’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9K Buy
263
+11
+4% +$488 ﹤0.01% 1677
2026
Q1 		$7.49K Sell
252
-9
-3% -$269 ﹤0.01% 1843
2025
Q4 		$9.97K Buy
261
+51
+24% +$1.66K ﹤0.01% 1576
2025
Q3 		$5.02K Buy
210
+10
+5% +$188 ﹤0.01% 1707
2025
Q2 		$2.96K Buy
200
+50
+33% +$829 ﹤0.01% 1799
2025
Q1 		$2.69K Buy
150
+40
+36% +$812 ﹤0.01% 1724
2024
Q4 		$1.92K Buy
110
+5
+5% +$88 ﹤0.01% 1828
2024
Q3 		$1.47K Buy
105
+85
+425% +$886 ﹤0.01% 1902
2024
Q2 		$164 Buy
20
+5
+33% +$34 ﹤0.01% 2548
2024
Q1 		$116 Buy
+15
New +$127 ﹤0.01% 2131

Other funds holding TVTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Rothschild Investment LLC's TVTX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Travere Therapeutics (TVTX) stake by 4.4% in Q2 2026, buying an estimated $488 and bringing the position to 263 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

Rothschild Investment LLC first reported a position in TVTX in Q1 2024 and has held it in 10 quarters since. 270 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Rothschild Investment LLC held 263 shares of Travere Therapeutics worth $14.9K as of Q2 2026.
  • Rothschild Investment LLC bought 11 Travere Therapeutics shares in Q2 2026, an estimated $488.
  • Travere Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1677 holding.
  • Rothschild Investment LLC first reported a position in Travere Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 270 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.